Apollo Hospitals’ FEMA case has been closed after an RBI compounding order and a ₹17.76 crore settlement. The ED issued a no-objection, ending adjudication proceedings against the company and five senior directors over alleged foreign exchange violations.

Apollo Hospitals Pays ₹17.76 Crore to Close FEMA Proceedings

The420 Correspondent
4 Min Read

New Delhi | A long-running foreign exchange compliance case involving healthcare giant and five of its senior directors has been brought to a close after the Reserve Bank of India (RBI) issued a compounding order under the Foreign Exchange Management Act (FEMA). The development has resulted in the termination of adjudication proceedings and related litigation that had been initiated following an Enforcement Directorate (ED) investigation into alleged foreign exchange violations.

According to information released by authorities, the case stemmed from an investigation into multiple alleged FEMA contraventions involving foreign investment transactions and regulatory compliance issues. After completing its probe, the ED had filed a complaint before the adjudicating authority under FEMA. However, the matter was later settled through the statutory compounding mechanism, which allows entities to resolve regulatory violations by paying a prescribed monetary amount instead of undergoing prolonged legal proceedings.

FCRF’s Flagship Cyber Law Certification Returns With a New Four-Week Cohort

Under the RBI’s compounding order, Apollo Hospitals made a one-time payment of approximately ₹17.76 crore. In addition, each of the five directors and officers named in the proceedings paid ₹18 lakh. Following these payments and the issuance of a “no objection” by the ED, the adjudication proceedings against the company and the concerned executives were formally terminated.

The case involved four categories of alleged FEMA violations that were examined during the investigation. Authorities stated that the transactions under scrutiny collectively involved more than ₹2,424 crore. Among the issues examined were allegations related to foreign direct investment, receipt of overseas funds under specific investment routes, issuance of foreign currency convertible bonds, and compliance with prescribed foreign shareholding limits.

The five directors and officers named in the proceedings were Preetha Reddy, Suneetha Reddy, S. K. Venkatraman, Akhileswaran Krishnan and S. M. Krishnan. Authorities clarified that the settlement applies to the specific FEMA contraventions covered under the compounding order and brings the related adjudication process to an end.

Regulatory experts note that compounding is an established mechanism under FEMA that enables individuals and companies to voluntarily resolve compliance violations. The process is generally viewed as a means of reducing litigation and encouraging regulatory compliance while ensuring that penalties are imposed for contraventions. Under such settlements, the payment of the prescribed amount and acceptance of the compounding order typically conclude the proceedings related to the identified violations.

The latest development is being seen as significant because it closes a high-profile case involving one of India’s largest healthcare providers. The RBI’s decision followed a review process in which the ED provided its no-objection to the compounding request. Officials indicated that the settlement was carried out in accordance with the provisions of FEMA and applicable regulatory procedures.

Legal and compliance professionals say the case highlights the growing importance of strict adherence to foreign investment and foreign exchange regulations, particularly for large corporations with complex ownership structures and international financial transactions. They point out that while compounding offers a route to settle regulatory disputes, companies are increasingly expected to maintain robust compliance frameworks to avoid future violations.

With the RBI’s order now in effect and the settlement amount paid, the proceedings against Apollo Hospitals and the five directors stand concluded, bringing an end to a matter that had attracted considerable attention in corporate and regulatory circles.

Stay Connected